Analysed BIOXYTRAN INC (BIXT:OTCMKTS) News Sources
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
10-12-2025
yahoo.com
Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19
02-03-2026
yahoo.com
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
04-03-2026
yahoo.com
Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research
29-07-2026
yahoo.com
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
04-08-2026
yahoo.com
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25
29-05-2026
yahoo.com
What is the current price of BIOXYTRAN INC (BIXT:OTCMKTS)?
The current price of BIOXYTRAN INC (BIXT:OTCMKTS) is $0.023.
BIOXYTRAN INC (BIXT:OTCMKTS) absolute price change since previous trading day?
The absolute price change of BIOXYTRAN INC (BIXT:OTCMKTS) since the previous trading day is $0.0007.
BIOXYTRAN INC (BIXT:OTCMKTS) percentage price change since previous trading day?
The percentage price change of BIOXYTRAN INC (BIXT:OTCMKTS) since the previous trading day is 3.139%.
What is the most recent average sentiment score for BIOXYTRAN INC (BIXT:OTCMKTS)?
The most recent average sentiment score for BIOXYTRAN INC (BIXT:OTCMKTS) is 65 out of 100.
What is the most recent average sentiment for BIOXYTRAN INC (BIXT:OTCMKTS)?
The most recent sentiment for BIOXYTRAN INC (BIXT:OTCMKTS) is .
SEC-8K** Filing Available For BIOXYTRAN INC (BIXT:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.